rs3761447

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000594306.1(PLA2G6):​c.-46+5761C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.469 in 151,474 control chromosomes in the GnomAD database, including 18,221 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 18221 hom., cov: 29)

Consequence

PLA2G6
ENST00000594306.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.34

Publications

2 publications found
Variant links:
Genes affected
PLA2G6 (HGNC:9039): (phospholipase A2 group VI) The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010]
PLA2G6 Gene-Disease associations (from GenCC):
  • neurodegeneration with brain iron accumulation 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • neurodegeneration with brain iron accumulation 2B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • PLA2G6-associated neurodegeneration
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive Parkinson disease 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000594306.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.582 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000594306.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLA2G6
ENST00000660610.1
c.-42+14921C>T
intron
N/AENSP00000499555.1O60733-1
PLA2G6
ENST00000594306.1
TSL:4
c.-46+5761C>T
intron
N/AENSP00000473160.1M0R3D9
ENSG00000298301
ENST00000754572.1
n.184+3754C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.469
AC:
71030
AN:
151356
Hom.:
18232
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.360
Gnomad AMR
AF:
0.488
Gnomad ASJ
AF:
0.547
Gnomad EAS
AF:
0.599
Gnomad SAS
AF:
0.386
Gnomad FIN
AF:
0.598
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.565
Gnomad OTH
AF:
0.492
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.469
AC:
71038
AN:
151474
Hom.:
18221
Cov.:
29
AF XY:
0.469
AC XY:
34693
AN XY:
73918
show subpopulations
African (AFR)
AF:
0.261
AC:
10801
AN:
41352
American (AMR)
AF:
0.488
AC:
7425
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
0.547
AC:
1895
AN:
3466
East Asian (EAS)
AF:
0.599
AC:
3063
AN:
5110
South Asian (SAS)
AF:
0.385
AC:
1851
AN:
4804
European-Finnish (FIN)
AF:
0.598
AC:
6229
AN:
10408
Middle Eastern (MID)
AF:
0.418
AC:
123
AN:
294
European-Non Finnish (NFE)
AF:
0.565
AC:
38298
AN:
67820
Other (OTH)
AF:
0.487
AC:
1025
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1631
3262
4893
6524
8155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
636
1272
1908
2544
3180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.503
Hom.:
2661
Bravo
AF:
0.457
Asia WGS
AF:
0.455
AC:
1578
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.70
DANN
Benign
0.90
PhyloP100
-1.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3761447;
hg19: chr22-38595539;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.